# OnCo record mucommune (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mucommune/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mucommune" ;
  schema:name "Mucommune"@en ;
  schema:alternateName "Mucommune, LLC"@en, "MUCOMMUNE, LLC"@en ;
  schema:description "Mucommune is a North Carolina biotechnology company that works on antibodies and immune-cell engineering. In cancer it is developing MM014, a way of turning a patient's own T cells into CAR-T cells inside the body, for solid tumours."@en ;
  schema:url <https://onco.cc/companies/mucommune/>, <https://www.mucommune.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.mucommune.com/>, <https://www.mucommune.com/pipeline>, <https://reporter.nih.gov/project-details/11413779> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/b7h3/> ;
  onco:drugs <https://onco.cc/drugs/mm014/> .
